Ireland · Investor

Seroba.

Last cheque observed Feb 2026; 8 cheques on record.

Deploying nowVC firm

Series ASeries BGrowthBiotechMedtech

Deploying now
14%of best year1cheques in 12 months, 8 on record
Since the last cheque250days00hrs00min00sec
Median round$32MRounds led3 of 8Mostly inUnited States, 38%
Pitch Seroba.

Seroba. highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 75% of its rounds

  3. 03

    Led 3 rounds

What they do

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.From their own website
Type
VC firm
Cheque size
Not stated
Sectors
BiotechMedtech
Based in
Dublin, Ireland
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2026

    1 round

  2. Feb
    Alveus Therapeutics Inc.Series A · US · Seroba Life Sciences$197MWith 8 others
  3. 2025

    3 rounds

  4. May
    AzafarosSeries B · NL · Seroba Life Sciences$147MWith 5 others
  5. Mar
    PerfuzeGrowth · IE · Seroba Life Sciences$24MLed
  6. Jan
    DeciphexSeries C · IE · Seroba Life Sciences$32MWith 9 others
  7. 2024

    4 rounds

  8. Oct
    ShiraTronicsSeries B · US · Seroba Life Sciences$66MWith 7 others
  9. Sept
    Ryme MedicalSeries A · US · Seroba Life SciencesUndisclosedWith 2 others
  10. Jul
  11. Jun
    Vico TherapeuticsSeries B · NL · Seroba Life Sciences$12MLed

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 6 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

9 of 15 we have independently watched raise

AzafarosFusion PharmaceuticalsMedlumicsPerfuzeQuantaRyme MedicalShiratronicsShorla OncologyStorm TherapeuticsLabcyteLociPalliarePrecision BioticsSibyllaVeryan

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as Seroba.. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Seroba. put money into.

Quick answers about Seroba.

What does Seroba. invest in?

Seroba. invests most often at Series A and Series B (75% of the rounds on record), in sectors such as Biotech and Medtech.

How active is Seroba.?

8 investments on record, 1 of them in the last 12 months, and it led 3. The most recent was in Feb 2026.

What has Seroba. invested in recently?

Its most recent investments on record: Alveus Therapeutics Inc. (Series A, Feb 2026), Azafaros (Series B, May 2025) and Perfuze (Growth, Mar 2025).

How big are Seroba.'s cheques?

The median round it joins is $32M.

Does Seroba. lead rounds?

Yes: it led 3 of its 8 investments on record (38%).

Where does Seroba. invest?

Most of the companies it backs are in the United States (38%), Ireland (38%) and the Netherlands (25%).

Is Seroba. investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Seroba. invest alongside?

Most often EQT (2 rounds together), EQT Life Sciences (2 rounds together) and Enterprise Ireland (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it